查看购物车
  • Traditional Chinese
  • English
亚太地区内皮功能障碍市场预测至 2028 年 - 区域分析 - 按原因、测试类型和最终用户
市场调查报告书
商品编码
1463689

亚太地区内皮功能障碍市场预测至 2028 年 - 区域分析 - 按原因、测试类型和最终用户

Asia Pacific Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause, Test Type, and End User
出版日期: | 出版商: The Insight Partners | 英文 128 Pages | 订单完成后即时交付

价格

亚太地区内皮CAGR障碍市场预计将从2022年的3.0448亿美元成长到2028年的4.0551亿美元。

新型生物标记和治疗策略的使用不断增加推动亚太内皮功能障碍市场

检查内皮功能可以改善风险分层，改善早期疾病检测，并评估血管对治疗介入的反应。有研究旨在更好地了解内皮功能障碍和动脉粥样硬化进展的病理生理机制，并确定新的生物标誌物和治疗策略来预防内皮功能障碍和动脉粥样硬化，从而降低患冠状动脉疾病( CAD) 和相关併发症的风险。使用液体活检和新的分子生物学技术，可以鑑定出越来越多的内皮功能障碍的分子和细胞标记物，这些标记物可以深入了解动脉粥状硬化的分子基础，以及预防和治疗动脉粥样硬化和动脉粥状硬化的潜在生物标记和治疗标靶。

过去几十年来，生物标记及其临床应用的研究呈指数级增长。全身性生物标记为动脉粥状硬化的病理生理学和新疗法的开发提供了宝贵的见解。内皮功能障碍和发炎在 CAD 的发生和进展中发挥核心作用。发炎介质由动脉粥状硬化斑块中的发炎细胞和血管细胞或肝臟或脂肪组织等器官分泌。

亚太地区内皮功能障碍市场概述

亚太地区的内皮功能障碍市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。该地区市场的成长归因于内皮功能障碍病例的增加，心血管疾病、高血压、糖尿病和慢性病发病率的上升，以及人口老化的加剧。此外，各国政府增加对诊断技术的投资推动了市场的发展，从而导致诊断方法的进步。

亚太地区内皮功能障碍市场收入及 2028 年预测（百万美元）

亚太地区内皮功能障碍市场区隔

亚太地区内皮功能障碍市场按原因、测试类型、最终用户和国家进行细分。

根据病因，亚太地区内皮功能障碍市场分为高血压、高胆固醇血症、肥胖、糖尿病、白塞氏症等。 2022 年，高血压细分市场在亚太地区内皮功能障碍市占率最大。

根据测试类型，亚太地区内皮功能障碍市场分为侵入性测试和非侵入性测试。到2022 年，侵入性测试领域将在亚太地区内皮功能障碍市场中占据更大份额。术、循环标记物等。

根据最终用户，亚太地区内皮功能障碍市场可分为医院、诊断中心、诊所等。 2022 年，医院细分市场占据亚太地区最大的内皮功能障碍市场。

根据国家/地区，亚太地区内皮功能障碍市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2022年，中国将主导亚太地区内皮功能障碍市场。

ZOLL Medical Corp、Sphingo Tec GmbH、Perimed AB 和 Medizinische Messtechnik GmbH 是该地区内皮功能障碍市场的一些领先公司。

目录

表中的内容

第 1 章：简介

第 2 章：亚太地区内皮功能障碍市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区内皮功能障碍市场 - 市场格局

  • 概述
  • PEST分析
    • 亚太地区 PEST 分析
  • 专家意见

第 5 章：亚太地区内皮功能障碍市场 - 主要市场动态

  • 市场驱动因素
    • 心血管疾病发生率增加
    • 高胆固醇、糖尿病和肥胖症的发生率上升
  • 市场限制
    • 内皮功能障碍筛检技术的缺点
  • 市场机会
    • 新型生物标记和治疗策略的使用不断增加
  • 未来的趋势
    • 使用非侵入性方法评估内皮功能障碍
  • 影响分析

第 6 章：内皮功能障碍市场 - 亚太地区分析

  • 亚太地区内皮功能障碍市场收入预测与分析

第 7 章：亚太地区内皮功能障碍市场分析 - 按原因

  • 概述
  • 亚太地区内皮功能障碍市场，依原因划分，2022 年和 2028 年 (%)
  • 高血压
  • 糖尿病
  • 高胆固醇血症
  • 白塞氏症
  • 肥胖
  • 其他的

第 8 章：亚太地区内皮功能障碍市场分析 - 按测试类型

  • 概述
  • 亚太地区内皮功能障碍市场，依测试类型，2022 年和 2028 年 (%)
  • 侵入性测试
  • 非侵入性测试

第 9 章：亚太地区内皮功能障碍市场分析 - 按最终用户

  • 概述
  • 亚太地区内皮功能障碍市场，按最终用户划分，2022 年和 2028 年 (%)
  • 医院
  • 诊断中心
  • 诊所
  • 其他的

第 10 章：亚太地区内皮功能障碍市场 - 收入与 2028 年预测 - 国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第 11 章：亚太地区内皮功能障碍市场-产业格局

  • 概述
  • 内皮功能障碍市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • ZOLL Medical Corp
  • Sphingo Tec GmbH
  • Perimed AB
  • Medizinische Messtechnik GmbH

第 13 章：附录

Product Code: BMIRE00029598

The Asia Pacific endothelial dysfunction market is expected to grow from US$ 304.48 million in 2022 to US$ 405.51 million by 2028. It is estimated to grow at a CAGR of 4.9% from 2022 to 2028.

Rising Usage of Novel Biomarkers and Therapeutic Strategies Fuels Asia Pacific Endothelial Dysfunction Market

Examining endothelial function can improve risk stratification, improve early disease detection, and assess vascular response to therapeutic interventions. There are studies to understand the pathophysiological mechanisms underlying endothelial dysfunction and atherosclerosis progression in a better way and identify new biomarkers and therapeutic strategies to prevent endothelial dysfunction and atherosclerosis to reduce the risk of developing coronary artery disease (CAD) and related complications. Using liquid biopsies and new molecular biology techniques has enabled the identification of a growing list of molecular and cellular markers of endothelial dysfunction that have provided insight into the molecular basis of atherosclerosis as well as potential biomarkers and therapeutic targets for the prevention and treatment of atherosclerosis and CAD.

Research on biomarkers and their clinical application has increased exponentially over the last few decades. Invaluable insight into the pathophysiology of atherosclerosis and the development of novel therapies have been provided by systemic biomarkers. Endothelial dysfunction and inflammation play a central role in the development and progression of CAD. Inflammatory mediators are secreted by inflammatory and vascular cells in atherosclerotic plaque or by organs such as the liver or adipose tissue.

Asia Pacific Endothelial Dysfunction Market Overview

The endothelial dysfunction market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the market in the region is attributed to the increasing cases of endothelial dysfunction with the rising incidence of CVD, hypertension, diabetes, and chronic diseases, coupled with the growing aging population. In addition, the market is driven by increasing investments in diagnostics techniques by the respective country governments, resulting in advancements in diagnostics methods.

Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Endothelial Dysfunction Market Segmentation

The Asia Pacific endothelial dysfunction market is segmented into cause, test type, end user, and country.

Based on cause, the Asia Pacific endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, Behcet's disease, and others. The hypertension segment registered the largest Asia Pacific endothelial dysfunction market share in 2022.

Based on test type, the Asia Pacific endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Asia Pacific endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the Asia Pacific endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Asia Pacific endothelial dysfunction market share in 2022.

Based on country, the Asia Pacific endothelial dysfunction market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific endothelial dysfunction market in 2022.

ZOLL Medical Corp, Sphingo Tec GmbH, Perimed AB, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Endothelial Dysfunction Market - by Cause
    • 1.3.2 Asia Pacific Endothelial Dysfunction Market - by Test Type
    • 1.3.3 Asia Pacific Endothelial Dysfunction Market - by End User
    • 1.3.4 Asia Pacific Endothelial Dysfunction Market - by Country

2. Asia Pacific Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Endothelial Dysfunction Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Asia Pacific PEST Analysis
  • 4.3 Expert Opinion

5. Asia Pacific Endothelial Dysfunction Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Cardiovascular Diseases
    • 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
  • 5.2 Market Restraints
    • 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
  • 5.3 Market Opportunities
    • 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
  • 5.4 Future Trends
    • 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
  • 5.5 Impact Analysis

6. Endothelial Dysfunction Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Endothelial Dysfunction Market Revenue Forecast and Analysis

7. Asia Pacific Endothelial Dysfunction Market Analysis - by Cause

  • 7.1 Overview
  • 7.2 Asia Pacific Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
  • 7.3 Hypertension
    • 7.3.1 Overview
    • 7.3.2 Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Hypercholestrolaemia
    • 7.5.1 Overview
    • 7.5.2 Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Behcet's Disease
    • 7.6.1 Overview
    • 7.6.2 Behcet's Disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Obesity
    • 7.7.1 Overview
    • 7.7.2 Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Endothelial Dysfunction Market Analysis - by Test Type

  • 8.1 Overview
  • 8.2 Asia Pacific Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
  • 8.3 Invasive Tests
    • 8.3.1 Overview
    • 8.3.2 Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Non-Invasive Tests
    • 8.4.1 Overview
    • 8.4.2 Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Flow Mediated Dilatory
      • 8.4.3.1 Overview
      • 8.4.3.2 Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.4 Venous Occlusion Plethysmography
      • 8.4.4.1 Overview
      • 8.4.4.2 Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.5 Peripheral Arterial Tonometry (PAT)
      • 8.4.5.1 Overview
      • 8.4.5.2 Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Circulating Markers
      • 8.4.6.1 Overview
      • 8.4.6.2 Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.7 Others
      • 8.4.7.1 Overview
      • 8.4.7.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Endothelial Dysfunction Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostics Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Clinics
    • 9.5.1 Overview
    • 9.5.2 Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Asia Pacific: Endothelial Dysfunction Market
    • 10.1.1 Overview
      • 10.1.1.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 China: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.1.4 China: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.1.4.1 China: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.1.5 China: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Japan: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.2.4 Japan: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.2.4.1 Japan: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.2.5 Japan: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.3 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 India: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.3.4 India: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.3.4.1 India: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.3.5 India: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.4 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Australia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.4.4 Australia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.4.4.1 Australia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.4.5 Australia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.5 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 South Korea: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.5.4 South Korea: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.5.4.1 South Korea: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.5.5 South Korea: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.6 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.6.4.1 Rest of Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.6.5 Rest of Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Asia Pacific Endothelial Dysfunction Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Endothelial Dysfunction Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 ZOLL Medical Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sphingo Tec GmbH
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Perimed AB
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Medizinische Messtechnik GmbH
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Techniques Used in to Assess Endothelial Function
  • Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
  • Table 3. China Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. China Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. China Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. China Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Japan Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Japan Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Japan Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Japan Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. India Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. India Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. India Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 14. India Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Australia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Australia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Australia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Australia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. South Korea Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. South Korea Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. South Korea Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 22. South Korea Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Rest of Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Rest of Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Rest of Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Rest of Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
  • Table 28. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
  • Table 29. Glossary of Terms, Endothelial dysfunction market

List Of Figures

  • Figure 1. Asia Pacific Endothelial Dysfunction Market Segmentation
  • Figure 2. Asia Pacific Endothelial Dysfunction Market, by Country
  • Figure 3. Asia Pacific Endothelial Dysfunction Market Overview
  • Figure 4. Hypertension Account for Largest Share of Cause Segment in Asia Pacific Endothelial Dysfunction Market
  • Figure 5. China Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Asia Pacific: PEST Analysis
  • Figure 7. Expert Opinion
  • Figure 8. Asia Pacific Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
  • Figure 9. Asia Pacific Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Asia Pacific Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
  • Figure 11. Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Behcet's disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Asia Pacific Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
  • Figure 18. Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Asia Pacific Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
  • Figure 26. Hospitals and Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Asia Pacific: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Asia Pacific: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 32. China: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. India: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Growth Strategies in the Endothelial Dysfunction Market